Urinary Bladder Neoplasms: all 1,649 studies
Page 13 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder CancerActive, not recruitingNCT02989584Phase 1/2
- Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBCTerminatedNCT02982395Phase 3
- Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic SurgeryCompletedNCT02977143Not applicable
- Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder CancerCompletedNCT02969109
- Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder TumorsCompletedNCT02966691Not applicable
- The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical TrialCompletedNCT02966535Not applicable
- Molecular Biosensors for Detection of Bladder CancerStatus unknownNCT02957370
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Bladder Cancer Adjuvant Radiotherapy TrialActive, not recruitingNCT02951325Phase 3
- A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder CancerStatus unknownNCT02951078Phase 3
- Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder CancerActive, not recruitingNCT02948543Phase 3
- Application-based Perioperative Management of the Radical Cystectomy PatientCompletedNCT02942121Not applicable
- Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial TractTerminatedNCT02925533Phase 1
- Intravenous Lidocaine for Cystectomy ProceduresCompletedNCT02924480Not applicable
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerCompletedNCT02897765Phase 1
- Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBCStatus unknownNCT02895620Not applicable
- Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC PatientsCompletedNCT02891460Not applicable
- Outpatient PDD Guided Laser Mediated Destruction of Bladder TumorsStatus unknownNCT02886026Not applicable
- Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder CancerCompletedNCT02885974Phase 1
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsActive, not recruitingNCT02869217Phase 1
- Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder CancersActive, not recruitingNCT02867865Phase 2/3
- PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder CancerWithdrawnNCT02863913Phase 1
- Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder CancerCompletedNCT02861196Not applicable
- Confocal Microscopy Dual Band in the Management of Bladder CancerCompletedNCT02857634
- Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral ResectionCompletedNCT02852564Phase 1
- Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A RegistryCompletedNCT02852252
- Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the BladderActive, not recruitingNCT02845323Phase 2
- Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)WithdrawnNCT02845050Phase 1/2
- The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder NeoplasiaStatus unknownNCT02841904Not applicable
- Measuring Urinary Nano Particles and Metallic Compounds in TCC PatientsCompletedNCT02811952
- uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder CancerStatus unknownNCT02805608Phase 2
- Validation of Endoscopic Bimodal Imager for the Bladder Cancer DetectionCompletedNCT02800473Not applicable
- Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology PatientsCompletedNCT02785887Not applicable
- To Detect the Sensitivity of the UroMark AssayCompletedNCT02781428
- Sexual Steroids: Relationship Between Serum and Prostatic Tissue LevelCompletedNCT02778243Not applicable
- sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney CancerTerminatedNCT02767921Phase 1
- TURBt With Adjuvant Cryoablation to Treat Bladder CancerStatus unknownNCT02760953Not applicable
- A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder CancerCompletedNCT02753309Early Phase 1
- External Beam Radiotherapy for Muscle Invasive Bladder CancerCompletedNCT02748200Phase 1
- Urinary Biomarkers in the Detection of Urothelial Carcinoma of the BladderCompletedNCT02745301
- Diode Laser Treatment of Bladder TumorsCompletedNCT02738827Not applicable
- Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder CarcinomaCompletedNCT02736266Phase 2
- MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder CancerTerminatedNCT02735512
- Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the BladderWithdrawnNCT02723838Phase 1
- Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder CancerCompletedNCT02722538Phase 1
- Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder CancerCompletedNCT02720367Phase 1
- Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder CancerStatus unknownNCT02716961Not applicable
- The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder CancerCompletedNCT02716623Not applicable
- Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable
- Observation Versus Immediate Surgery of Low Risk Bladder CancerTerminatedNCT02700724Not applicable
- The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell CarcinomaCompletedNCT02700464Not applicable
- Ultrasound-Guided ONB for Transurethral Procedures - Interadductor ApproachStatus unknownNCT02696733Phase 4
- Cancer in Patients on Dapagliflozin and Other Antidiabetic TreatmentCompletedNCT02695121
- Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder CancerWithdrawnNCT02688348Not applicable
- Detecting Bladder Cancer Using the UroMark Test.CompletedNCT02676180
- Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersCompletedNCT02675829Phase 2
- A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionCompletedNCT02665039Phase 2
- Preoperative MPDL3280A in Transitional Cell Carcinoma of the BladderCompletedNCT02662309Phase 2
- MRI in Clinical Staging and Estimation of Treatment Response in Bladder CancerCompletedNCT02662166Not applicable
- Laser Treatment of Bladder Tumors in the Outpatient DepartmentStatus unknownNCT02659332Not applicable
- Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical CystectomyCompletedNCT02655081Phase 2
- Basal Like Bladder Cancer : Signature and TherapeuticStatus unknownNCT02648100
- Utility of Bladder EpiCheck for Detection of Recurrent Urothelial CarcinomaCompletedNCT02647112Not applicable
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)TerminatedNCT02625961Phase 2
- Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted SurgeryStatus unknownNCT02600481Not applicable
- Comparing Rectus Sheath Catheter to Epidural Post CystectomyStatus unknownNCT02572804Not applicable
- Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)CompletedNCT02555163Not applicable
- Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury IndividualsTerminatedNCT02538809
- Postoperative Quality of Recovery After Transurethral Resection of the BladderStatus unknownNCT02534623Not applicable
- BLADDER CANCER SCREENING AMONG DIABETIC PATIENTSCompletedNCT02505516Early Phase 1
- Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational PlanStatus unknownNCT02496442Not applicable
- Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsActive, not recruitingNCT02496208Phase 1
- Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder CancerTerminatedNCT02494635
- CIK in Treating Patients With Bladder CancerActive, not recruitingNCT02489890Phase 2
- RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)WithdrawnNCT02471495Phase 3
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder StagingCompletedNCT02462239Not applicable
- T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesStatus unknownNCT02457650Phase 1
- Study of Tumour Focused Radiotherapy for Bladder CancerActive, not recruitingNCT02447549Phase 2
- Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and ProgressionStatus unknownNCT02443844Phase 4
- PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)CompletedNCT02439060Not applicable
- Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.CompletedNCT02438865Phase 2
- Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder CancerWithdrawnNCT02438852Phase 3
- Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyCompletedNCT02437539Phase 1
- Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial CancerCompletedNCT02437370Phase 1
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- Irreversible Electroporation(IRE) For Unresectable Urinary Bladder NeoplasmsCompletedNCT02430623Not applicable
- Cystoscopic Imaging Collection and Enhancement pROjectCompletedNCT02427321
- Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomyStatus unknownNCT02422277Phase 2
- PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare ProvidersCompletedNCT02408406Not applicable
- Determinants of Bladder Cancer Recurrence Study (The DETER Study)Active, not recruitingNCT02400944
- Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder CancerActive, not recruitingNCT02397434Not applicable
- Sexual Function in Patients Suspected of Non-muscle Invasive Bladder CancerCompletedNCT02381912
- VPM1002BC in Recurrent Non-muscle Invasive Bladder CancerCompletedNCT02371447Phase 1/2
- Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG FailureCompletedNCT02365818Phase 2
- Metformin and Simvastatin Use in Bladder CancerStatus unknownNCT02360618Phase 2
- Peri-operative Aspirin Continuation Versus DiscontinuationTerminatedNCT02350543Phase 4
- Open Versus Laparoscopic Radical CystectomyStatus unknownNCT02345499Phase 2